These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2656523)

  • 1. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice.
    Tanaka T; Okamura S; Okada K; Suga A; Shimono N; Ohhara N; Hirota Y; Sawae Y; Niho Y
    Infect Immun; 1989 Jun; 57(6):1792-9. PubMed ID: 2656523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.
    Mayer P; Schütze E; Lam C; Kricek F; Liehl E
    J Infect Dis; 1991 Mar; 163(3):584-90. PubMed ID: 1995731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus.
    Frenck RW; Sarman G; Harper TE; Buescher ES
    J Infect Dis; 1990 Jul; 162(1):109-14. PubMed ID: 2192004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.
    Matsumoto M; Matsubara S; Matsuno T; Tamura M; Hattori K; Nomura H; Ono M; Yokota T
    Infect Immun; 1987 Nov; 55(11):2715-20. PubMed ID: 2444540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on Pseudomonas infection.
    Matsumoto M; Tamura M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1991; 35(6):461-74. PubMed ID: 1717812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of ren-shen-yang-rong-tang (Ninjin-youei-to) in mice with drug-induced leukopenia against Pseudomonas aeruginosa infection.
    Miura S; Takimoto H; Yoshikai Y; Kumazawa Y; Yamada A; Nomoto K
    Int J Immunopharmacol; 1992 Oct; 14(7):1249-57. PubMed ID: 1280629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors.
    Talmadge JE; Tribble H; Pennington R; Bowersox O; Schneider MA; Castelli P; Black PL; Abe F
    Blood; 1989 Jun; 73(8):2093-103. PubMed ID: 2471557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.
    Bermudez LE; Martinelli JC; Gascon R; Wu M; Young LS
    Cytokine; 1990 Jul; 2(4):287-93. PubMed ID: 1966550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
    Mitsuyasu RT; Golde DW
    Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor.
    Sawaki M; Kita E; Mikasa K; Konishi M; Kumimatsu M; Kashiba S; Narita N
    Biotherapy; 1993; 6(1):51-61. PubMed ID: 7685182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.
    Yasuda H; Ajiki Y; Shimozato T; Kasahara M; Kawada H; Iwata M; Shimizu K
    Infect Immun; 1990 Aug; 58(8):2502-9. PubMed ID: 1695205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.